more_reports

Kadmon Holdings Inc.

KDMN:NYSE

Developing first-in-class, innovative therapies for indications with significant unmet medical needs, including autoimmune and fibrotic diseases, oncology and genetic diseases.

streetwise book logo Streetwise Company Fact Sheet

2024/12/23 0:00:21

(KDMN:NYSE)